title: The pediatric cardiology pharmacopeia: 2013 update.
abstract: The use of medications plays a pivotal role in the management of children with heart diseases. Most children with increased pulmonary blood flow require chronic use of anticongestive heart failure medications until more definitive interventional or surgical procedures are performed. The use of such medications, particularly inotropic agents and diuretics, is even more amplified during the postoperative period. Currently, children are undergoing surgical intervention at an ever younger age with excellent results aided by advanced anesthetic and postoperative care. The most significant of these advanced measures includes invasive and noninvasive monitoring as well as a wide array of pharmacologic agents. This review update provides a medication guide for medical practitioners involved in care of children with heart diseases.
authors.affiliation: Department of Pediatrics, Rush University Medical Center, 1653 W Congress Parkway, Chicago, IL 60612, USA. Paul_N_Severin@rush.edu
authors.forename: Paul Nicholas
authors.initials: PN
authors.lastname: Severin
authors.forename: Sawsan
authors.initials: S
authors.lastname: Awad
authors.forename: Beth
authors.initials: B
authors.lastname: Shields
authors.forename: Joan
authors.initials: J
authors.lastname: Hoffman
authors.forename: William
authors.initials: W
authors.lastname: Bonney
authors.forename: Edmundo
authors.initials: E
authors.lastname: Cortez
authors.forename: Rani
authors.initials: R
authors.lastname: Ganesan
authors.forename: Aloka
authors.initials: A
authors.lastname: Patel
authors.forename: Steve
authors.initials: S
authors.lastname: Barnes
authors.forename: Sean
authors.initials: S
authors.lastname: Barnes
authors.forename: Shada
authors.initials: S
authors.lastname: Al-Anani
authors.forename: Umang
authors.initials: U
authors.lastname: Gupta
authors.forename: Yolandee Bell
authors.initials: YB
authors.lastname: Cheddar
authors.forename: Ismael E
authors.initials: IE
authors.lastname: Gonzalez
authors.forename: Kiran
authors.initials: K
authors.lastname: Mallula
authors.forename: Hani
authors.initials: H
authors.lastname: Ghawi
authors.forename: Suhaib
authors.initials: S
authors.lastname: Kazmouz
authors.forename: Salwa
authors.initials: S
authors.lastname: Gendi
authors.forename: Ra-id
authors.initials: RI
authors.lastname: Abdulla
mesh_terms: D002309:Cardiology; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002648:Child; D019468:Disease Management; D006331:Heart Diseases / Q000188:drug therapy*; D006801:Humans; D010372:Pediatrics; D010602:Pharmacopoeias as Topic
chemical_list: D002317:Cardiovascular Agents